E-Mail
IMAGE: Lead researcher Adnan I. Qureshi, MD, a professor of clinical neurology at the MU School of Medicine. view more
Credit: Justin Kelley
A review of nearly 28,000 emergency department records shows less than 2% of patients diagnosed with COVID-19 suffered an ischemic stroke but those who did had an increased risk of requiring long-term care after hospital discharge. Those are the findings from a study conducted by researchers from the University of Missouri School of Medicine and MU Health Care.
The researchers teamed up with the MU Institute for Data Science and Informatics and the Tiger Institute for Health Innovation to review data from 54 health care facilities. They found 103 patients (1.3%) developed ischemic stroke among 8,163 patients with COVID-19. Comparatively, 199 patients (1.0%) developed stroke among 19,513 patients who didn t have COVID-19.
Whether alcohol withdrawal rates among hospitalized patients with alcohol use disorder increased during the COVID-19 pandemic was examined in this study.
Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM.
Des Plaines, IL - Initial management with inhaled methoxyflurane in the emergency department did not achieve the prespecified substantial reduction in pain, but was associated with clinically significant lower pain scores compared to standard therapy. That is the conclusion of a study titled Rapid Administration of Methoxyflurane to Patients in the Emergency Department (RAMPED) Study: A Randomized Controlled Trial of Methoxyflurane Versus Standard Care that was published recently in the February 2021 issue of
Academic Emergency Medicine (
AEM), a journal of the Society for Academic Emergency Medicine (SAEM).
This study investigates emergency department visits for violence-related injuries occurring at home and outside the home in Cardiff, Wales, before and after COVID-19 lockdown measures were instituted in March 2020.
E-Mail
PHILADELPHIA Hospital emergency departments (EDs) not only care for patients with overdose and other complications from opioid use, but they also serve as vital touch points to engage patients into longer-term treatment. After an overdose, patients are at risk for repeat overdose and death. Pennsylvania is unique in establishing a voluntary incentive program to improve the rate at which patients with opioid use disorder receive follow-up treatment after emergency department care. Evaluations of the program show that financial incentives are effective in producing rapid treatment innovations for opioid use disorder.
In a study, researchers at the Perelman School of Medicine at the University of Pennsylvania found that Pennsylvania s financial incentive policy encouraged hospitals to enact rapid system and practice changes to support treatment for opioid use disorder for patients visiting the ED. The study, which was recently published in